Related Experiment Video
Updated: Jul 10, 2026
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
p15Ink4b: dual function in myelopoiesis and inactivation in myeloid disease
Michael Rosu-Myles1, Linda Wolff
1Center for Cancer Research, National Cancer Institute, NIH, Building 37, Room 4124A, 37 Convent Drive MSC 4263, Bethesda, MD 20892-4263, USA.
Abstract:
p15Ink4b (p15) is a cyclin-dependent kinase inhibitor (CDKI) that is known for arresting the cell cycle in early G1 phase by inhibiting the activation of cyclin dependent kinases 4 and 6. Loss of p15 expression has been associated with several cancer types but its silencing is frequent in acute myeloid leukemia (AML) and myeloid dysplastic syndrome (MDS). Several mechanisms have been identified that are responsible for silencing the gene encoding p15 in myeloid disease, including gene hypermethylation, transcription factor deregulation and direct inhibition by translocation products. The effect of p15 loss during disease may be attributed to the dual role of this protein as a mediator of cell cycle arrest in late stage myeloid progenitors and as a regulator of differentiation in early common myeloid progenitors (CMP). Here we outline the mechanisms by which p15 is silenced and the functions of this CDKI in myelopoiesis as well as discuss the implications of these findings to myeloid disease.
Insights
The p15Ink4b protein, a cell cycle inhibitor, is frequently silenced in acute myeloid leukemia and myeloid dysplastic syndrome. Understanding p15 silencing mechanisms and its role in myelopoiesis is crucial for myeloid disease treatment.
Area of Science:
- Molecular Biology
- Oncology
- Hematology
Background:
- p15Ink4b (p15) is a cyclin-dependent kinase inhibitor (CDKI) that halts cell cycle progression.
- Loss of p15 expression is common in acute myeloid leukemia (AML) and myeloid dysplastic syndrome (MDS).
Purpose of the Study:
- To outline mechanisms of p15 gene silencing in myeloid diseases.
- To elucidate the functions of p15 in myelopoiesis.
- To discuss the implications of p15 loss in myeloid malignancies.
Main Methods:
- Review of existing literature on p15Ink4b silencing mechanisms.
- Analysis of p15's role in cell cycle arrest and differentiation.
- Discussion of p15's relevance to AML and MDS pathogenesis.
Main Results:
- p15 silencing occurs via gene hypermethylation, transcription factor deregulation, and translocation products.
- p15 regulates cell cycle arrest in late myeloid progenitors and differentiation in early common myeloid progenitors (CMP).
Conclusions:
- p15Ink4b plays a critical dual role in myeloid development.
- p15 silencing contributes to the pathogenesis of AML and MDS.
- Targeting p15 may offer therapeutic strategies for myeloid disorders.
More Related Videos
Related Concept Videos
02:23Abnormal Proliferation
01:01Regulation of Hematopoietic Stem Cells
01:15Differentiation of Common Myeloid Progenitor Cells
01:21Lineage Commitment